AngioDynamics: AngioDynamics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended May 31, 2026

AngioDynamics, Inc. reported earnings results for the fourth quarter and full year ended May 31, 2026. For the fourth quarter, the company reported sales was USD 86.61 million compared to USD 80.16 million a year ago. Net loss was USD 11.41 million compared to USD 6.05 million a year ago. Basic loss per share from continuing operations was USD 0.27 compared to USD 0.15 a year ago. Diluted loss per share from continuing operations was USD 0.27 compared to USD 0.15 a year ago. For the full year, sales was USD 320.17 million compared to USD 292.5 million a year ago. Net loss was USD 36.74 million compared to USD 33.99 million a year ago. Basic loss per share from continuing operations was USD 0.88 compared to USD 0.83 a year ago. Diluted loss per share from continuing operations was USD 0.88 compared to USD 0.83 a year ago.